Bleakley Financial Group, LLC Charles River Laboratories International, Inc. Transaction History

Bleakley Financial Group, LLC

  • $3.28 Trillion
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 08, 2024
BUY
$203.52 - $273.43 $167,904 - $225,579
825 New
825 $224 Million
Q2 2023

Aug 14, 2023
SELL
$183.71 - $210.25 $6,797 - $7,779
-37 Reduced 3.53%
1,012 $213 Million
Q1 2023

May 12, 2023
SELL
$191.89 - $259.92 $53,729 - $72,777
-280 Reduced 21.07%
1,049 $212 Million
Q4 2022

Feb 07, 2023
BUY
$197.11 - $250.07 $261,959 - $332,343
1,329 New
1,329 $290 Million

Others Institutions Holding CRL

# of Institutions
698
Shares Held
52.3M
Call Options Held
259K
Put Options Held
463K
View Full List

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.

CRL Quotes by TradingView
  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $10.1B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Bleakley Financial Group, LLC Portfolio

Follow Bleakley Financial Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bleakley Financial Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bleakley Financial Group, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email